CRIS (Curis Inc) Stock Analysis - Insider Trades

Curis Inc (CRIS) is a publicly traded Healthcare sector company. As of May 21, 2026, CRIS trades at $0.50 with a market cap of $18.71M and a P/E ratio of -0.62. CRIS moved +4.22% today. Year to date, CRIS is -49.71%; over the trailing twelve months it is -76.64%. Its 52-week range spans $0.46 to $5.54. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces CRIS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CRIS stock inside the company?

Recent CRIS insider activity includes KAITIN KENNETH I bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CRIS Key Metrics

Key financial metrics for CRIS
MetricValue
Price$0.50
Market Cap$18.71M
P/E Ratio-0.62
EPS$-0.81
Dividend Yield0.00%
52-Week High$5.54
52-Week Low$0.46
Volume1
Avg Volume0
Revenue (TTM)$7.06M
Net Income$-21.16M
Gross Margin0.00%

Recent CRIS Insider Trades

  • KAITIN KENNETH I bought 10.00K (~$5.49K) on Mar 31, 2026.

Latest CRIS News

CRIS Analyst Consensus

3 analysts cover CRIS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.

Common questions about CRIS

Who is trading CRIS stock inside the company?
Recent CRIS insider activity includes KAITIN KENNETH I bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CRIS?
Yes. Rallies tracks CRIS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CRIS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CRIS. It does not provide personalized investment advice.
CRIS

CRIS